TRIM28 and prostate neoplasm: Although our analysis in this study focused on the expression of ERVs at 1 month after Trim28 deletion in NPp53T prostate tumors, RT-qPCR analysis confirmed persistent ERV expression up to 3 months post-Trim28 deletion.